C World Wide Group Holding A Bluebird Bio, Inc. Transaction History

C World Wide Group Holding A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 03, 2019	SELL	$64.44 - $104.11 $153,431 - $247,885	-2,381 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$59.1 - $93.26 $3,605 - $5,688	-61 Reduced 2.5%	2,381 $236,000
Q3 2018 Nov 05, 2018	BUY	$88.86 - $117.49 $30,567 - $40,416	344 Added 16.4%	2,442 $357,000
Q1 2018 May 03, 2018	SELL	$105.8 - $150.94 $6,771 - $9,660	-64 Reduced 2.96%	2,098 $358,000
Q4 2017 Feb 07, 2018	SELL	$81.25 - $130.7 $25,350 - $40,778	-312 Reduced 12.61%	2,162 $385,000
Q3 2017 Nov 06, 2017	BUY	$57.74 - $91.42 $142,848 - $226,173	2,474	2,474 $340,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.